Sample Collection and Testing System

Details for Australian Patent Application No. 2007216739 (hide)

Owner Biocontrol Systems, Inc.

Inventors Di Carlo, Joseph B.; Andersen, Mark; Christensen, Jim; Feldsine, Philip T.; Kressner, Anita; Kelly, Tim A.

Agent Davies Collison Cave

Pub. Number AU-A-2007216739

Parent 2003231770

Filing date 5 September 2007

Wipo publication date 25 October 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 21/76 (2006.01) Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light - Chemiluminescence

G01N 21/78 (2006.01) Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light

G01N 33/02 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Food

Event Publications

27 September 2007 Complete Application Filed

25 October 2007 Application Open to Public Inspection

  Published as AU-A-2007216739

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007216740-Use of erythritol and d-tagatose in zeroor low-calorie beverages and food products

2007216738-Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways